BridgeBio Pharma announces $150M public offering

Mar. 06, 2023 4:27 PM ETBridgeBio Pharma, Inc. (BBIO)By: Dania Nadeem, SA News Editor
  • BridgeBio Pharma (NASDAQ:BBIO) said it had begun an underwritten public offering of $150M of shares of its common stock.
  • BridgeBio also expects to grant the underwriters a 30-day option to purchase up to an additional $22.5M of shares.
  • Goldman Sachs & Co, Evercore, and Morgan Stanley are acting as book-running managers for the proposed offering.
  • Press Release

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.